2026-01-05 - Analysis Report
Okay, here's a comprehensive analysis of Air Products and Chemicals Inc. (APD) based on the provided data.

**0) Overall Summary**

APD is currently underperforming the S&P 500 (VOO) significantly.  Its recent performance and analyst outlook are mixed. News suggests both challenges and positive developments (particularly related to hydrogen projects).  While some indicators like the MRI suggest medium investment, the expected return is drastically negative, requiring careful consideration and further investigation.

**1) Return Rate Comparison (APD vs. VOO)**

*   **APD:** Air Products and Chemicals Inc. is an industrial gases company.
*   **APD Cumulative Return:** -10.43%
*   **VOO (S&P 500) Cumulative Return:** 91.00%
*   **Divergence:** -101.4 (Relative Divergence: 5.2)

**Analysis:**

The divergence is very large and negative. APD has significantly underperformed the S&P 500. The relative divergence of 5.2 indicates that the current divergence is near its historical worst within the analyzed period.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha   | Beta   | Cap(B) |
|------------|----------|----------|---------|--------|--------|
| 2016-2018  | 6.0%     | 12.1%    | 2.0%    | 0.9    | 35.6   |
| 2017-2019  | 34.0%    | 12.1%    | 17.0%   | 0.9    | 52.3   |
| 2018-2020  | 17.0%    | 20.5%    | -4.0%   | 1.0    | 60.8   |
| 2019-2021  | 41.0%    | 20.5%    | -3.0%   | 1.0    | 67.7   |
| 2020-2022  | 4.0%     | 28.5%    | 6.0%    | 0.9    | 68.6   |
| 2021-2023  | -26.0%   | 28.5%    | -27.0%  | 0.8    | 61.0   |
| 2022-2024  | -36.0%   | 31.2%    | -56.0%  | 0.7    | 64.6   |
| 2023-2025  | -61.0%   | 31.2%    | -123.0% | 0.7    | 55.0   |

**Analysis:**

*   **CAGR:**  The compounded annual growth rate has deteriorated significantly, going from positive to deeply negative in recent periods.
*   **MDD:** Maximum Drawdown is increasing. This indicates that the stock price has been experiencing bigger drops from its peak, signaling increased volatility and risk.
*   **Alpha:**  Alpha, which measures performance relative to a benchmark (adjusted for risk), is strongly negative and worsening, suggesting APD is significantly underperforming expectations.
*   **Beta:** Beta hovers around 1 but slightly decreased recently, meaning that APD generally moves in tandem with the market, but slightly less volatile than the overall market, and even less so recently.
*   **Cap:** Market cap initially increased and has started to decrease recently.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 250.47
*   **Previous Close:** 245.23
*   **Change:** 2.14
*   **5-day SMA:** 248.32
*   **20-day SMA:** 245.34
*   **60-day SMA:** 252.01

**Analysis:**

The stock is currently trading above its 5-day and 20-day moving averages, suggesting short-term upward momentum. The price is rebounding towards the 60-day moving average. The change of 2.14 is not extremely high, but significant given the low recent performance.

**3) Technical Indicators**

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment)
*   **RSI (Relative Strength Index):** 61.17
*   **PPO (Percentage Price Oscillator):** 0.44
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (6 shares - Safe - MRI:0.80) Dividend_1.79 Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2026-01-02)
*   **Recent (20 days) Relative Divergence Change:** 3.4 (+): Short-term increase
*   **Expected Return (%):** -576.1%

**Analysis:**

*   **MRI:** A reading of 0.8 indicates a medium level of investment risk according to this indicator.
*   **RSI:** An RSI of 61.17 suggests the stock is neither overbought nor oversold, trending slightly toward the overbought territory.
*   **PPO:** A PPO of 0.44 indicates that the shorter-term moving average is slightly above the longer-term moving average, suggesting potential short-term upward momentum.
*   **Hybrid Signal:** The hybrid signal advocates for a buy strategy.
*   **Relative Divergence Change:** The increase in relative divergence over the past 20 days suggests recent improvement in the stock's performance compared to the S&P 500, but within the context of a very large divergence.
*   **Expected Return:** The dramatically negative expected return of -576.1% is alarming and requires deep investigation.  This suggests the model anticipates significant continued underperformance.

**4) Recent News & Significant Events**

*   **Forbes:** "What's Next With APD Stock After A 25% Drop?" - Highlights recent price weakness.
*   **Yahoo Finance/MSN:** Bernstein maintains/reiterates "Outperform" rating following hydrogen megaproject announcements and a Yara partnership update - Positive outlook related to specific projects.
*   **MarketBeat:** Air Products and Chemicals (NYSE:APD) Stock Unloaded Rep. Julie Johnson - Suggests potential political/insider selling pressure (not necessarily indicative of fundamental issues).
*   **Trefis:** "Whatâ€™s Next For Air Products Stock?" - General outlook piece; further research would be needed to assess its specific conclusions.
*   **Seeking Alpha:** Air Products And Chemicals: De-Risking Moves Support A Re-Rating (NYSE:APD) - Potentially positive take, suggesting actions taken by the company may lead to a better valuation.

**Analysis:**

The news paints a mixed picture.  While analysts seem optimistic about the long-term potential related to hydrogen projects, the Forbes headline highlights recent price declines. Political factors may also be impacting the stock.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.13)
*   **Opinions:** 21
*   **Target Price:** Avg: 292.86 / High: 340.00 / Low: 245.00

**Analysis:**

The analyst consensus is a "Buy" with a mean rating of 2.13.  The average target price suggests potential upside from the current price. However, the low target price is below the current price, indicating disagreement among analysts. The lack of information on recent rating changes prevents any analysis.

**5) Recent Earnings Analysis**

| Date       | EPS     | Revenue  |
|------------|---------|----------|
| 2025-07-31 | 3.2     | 3.02 B$  |
| 2025-05-01 | -7.77    | 2.92 B$  |
| 2025-02-06 | 2.77    | 2.93 B$  |
| 2024-08-01 | 3.13    | 2.99 B$  |
| 2025-07-31 | 3.13    | 2.99 B$  |

**Analysis:**

The EPS data is volatile, showing a large loss in May 2025. The revenue has been relatively consistent. The inconsistency between EPS and revenue calls for further investigation. Note that the 2025-07-31 line is repeated, there is likely an error in this table.

**6) Financial Information**

Revenue and Profitability:

| Quarter    | Revenue  | Profit Margin |
|------------|----------|----------------|
| 2025-09-30 | $3.17B   | 32.25%         |
| 2025-06-30 | $3.02B   | 32.51%         |
| 2025-03-31 | $2.92B   | 29.57%         |
| 2024-12-31 | $2.93B   | 31.21%         |
| 2024-09-30 | $3.19B   | 33.98%         |

Capital and Profitability:

| Quarter    | Equity    | ROE      |
|------------|-----------|----------|
| 2025-09-30 | $15.02B  | 0.03%    |
| 2025-06-30 | $15.54B  | 4.59%    |
| 2025-03-31 | $14.70B  | -11.77%   |
| 2024-12-31 | $16.69B  | 3.70%    |
| 2024-09-30 | $17.04B  | 11.45%   |

**Analysis:**

*   **Revenue:** Revenue has fluctuated slightly but remained relatively consistent.
*   **Profit Margin:** Profit margins have also been relatively stable but dipped in the quarter ending March 31, 2025.
*   **Equity:** Equity has generally decreased over the period, which might raise concerns.
*   **ROE:** ROE (Return on Equity) is highly volatile, with a significant negative value in March 2025 and a very low value in September 2025. This is concerning and warrants further investigation.

**7) Comprehensive Analysis**

*   **Underperformance:** APD has significantly underperformed the S&P 500.
*   **Analyst Sentiment:** Analysts generally have a positive outlook, but target prices vary, and recent earnings are inconsistent.
*   **News:** News is mixed, with positive developments around hydrogen projects offset by concerns about recent price declines and political selling.
*   **Financial Health:** Revenue and profit margins are reasonably stable, but the decreasing equity and volatile ROE are concerning. The deeply negative expected return is a major red flag.
*   **Technicals:** Short-term technical indicators suggest some recent upward momentum, but the overall picture is still negative.
*   **Recommendation:**  Based on this data, a cautious approach is warranted. While analysts are generally positive, the financial data and performance divergence suggest significant risks. Further research into the reasons for the negative expected return, the ROE volatility, and the potential impact of the hydrogen projects is crucial before making any investment decisions.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.